27.68
7.06%
+1.84
Schlusskurs vom Vortag:
$25.84
Offen:
$27.8
24-Stunden-Volumen:
1.19M
Marktkapitalisierung:
$1.86B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-18.51%
1M Leistung:
-30.40%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
CG Oncology, Inc. Stock (CGON) Company Profile
Firmenname
CG Oncology, Inc.
Sektor
Branche
Telefon
(949) 419-6203
Adresse
400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE
CG Oncology, Inc. Stock (CGON) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-02-14 | Eingeleitet | H.C. Wainwright | Buy |
CG Oncology, Inc. Aktie (CGON) Neueste Nachrichten
Decoding 10 Analyst Evaluations For CG Oncology
Benzinga
Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
GlobeNewswire Inc.
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
GlobeNewswire Inc.
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
GlobeNewswire Inc.
How to Find Up-and-Coming Stocks to Buy Right Now
Zacks Investment Research
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
The Motley Fool
Finanzdaten der CG Oncology, Inc.-Aktie (CGON)
Es liegen keine Finanzdaten für CG Oncology, Inc. (CGON) vor. Überprüfen Sie andere Aktien für weitere Informationen.
CG Oncology, Inc.-Aktie (CGON) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Song Hong Fang | Director |
Jan 29 '24 |
Buy |
19.00 |
263,157 |
4,999,983 |
613,928 |
Roche Corleen M. | CFO & Secretary |
Jan 29 '24 |
Buy |
19.00 |
2,000 |
38,000 |
2,000 |
Kasturi Vijay | Chief Medical Officer |
Jan 29 '24 |
Buy |
19.00 |
1,315 |
24,985 |
1,315 |
Kapitalisierung:
|
Volumen (24h):